Clinical Trial Update: Investigating Measurable PRO Acuity Trial (IMPACT) is a Multi-Center Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Maraviroc and Atorvastatin to Improve Neurocognitive and Physical Function of Subjects With Long COVID-19/Post-Acute Sequelae of COVID-19 (PASC). [Phase 2, Phase 3]

View source ↗

Summary

A multi-center randomized trial called IMPACT is evaluating the combination of maraviroc and atorvastatin to improve neurocognitive and physical function in lon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Lipitor (atorvastatin)
• Selzentry (Maraviroc)

Snippet

Sponsor: HealthBio, Inc. | Conditions: Long COVID | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING